Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shockwaves could soothe Runner's knee pain

NCT ID NCT07668011

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding radial shockwave therapy to standard exercises can reduce pain and improve leg function in people with iliotibial band syndrome (ITBS). Forty physically active adults aged 18–45 with recent ITBS will be split into two groups: one gets real shockwave therapy plus exercise, the other gets a sham treatment plus exercise. The goal is to see if the shockwaves provide extra relief for this common running injury.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Radial Extracorporeal Shockwave Therapy (rESWT)
What this could lead to
If it works, this could offer a non-invasive way to ease knee pain and speed recovery for active people with IT band syndrome.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply to everyone. The sham group also gets exercise, so the added benefit of shockwave therapy may be small or unclear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Physically active individuals aged 18 and 45 years * Have a clinical diagnosis of iliotibial band syndrome (ITBS) confirmed by physician within the previous four weeks. * Report lateral knee pain during running or other functional activities * No history of direct trauma * Have a positive Noble compression or/and Ober test. Exclusion Criteria: * History of knee surgery,fracture , meniscal or ligamentous injury within the past year * Any fracture involving the lower extremity within the previous six months * Neurological disorders * Lumbar radiculopathy * Systemic inflammatory disease * Any medical condition affecting gat or lower extremity function. * Have received corticosteroid injection, shockwave therapy, or physical therapy treatment for ITBS within the previous six months * Use of NDAID's or analgesics later than 2 weeks * Individuals with contraindications to ESWT, including pregnancy, bleeding disorders, or use of anticoagulant medication.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Iliotibial band syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Iliotibial Band Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Iliotibial band syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cairo University Hospitals

    RECRUITING

    Giza, Giza Governorate, 2356, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.